Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT04432922 Completed - COVID19 Clinical Trials

Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection

Start date: November 1, 2020
Phase:
Study type: Observational

The aim of this study is to analyze the perceptions, representations and experiences of septic isolation of patients hospitalized for COVID-19 infection. This analysis could lead to better understanding and communication between the medical profession and patients in septic isolation in hospital. It would also provide patient-specific responses to their expectations, as to their families.

NCT ID: NCT04432324 Completed - COVID-19 Clinical Trials

Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)

Start date: June 2, 2020
Phase: Phase 2
Study type: Interventional

The purpose of the study is to determine if high dose Intravenous IVIG plus SMT can reduce the proportion of participants dying or requiring intensive care unit (ICU) admission on or before Day 29 or who are dependent on high flow oxygen devices or invasive mechanical ventilation on Day 29 versus SMT alone in hospitalized participants with COVID-19.

NCT ID: NCT04432051 Completed - Ultrasonography Clinical Trials

The Use of Lung Ultrasonography in COVID-19 Patients

Start date: May 26, 2020
Phase: N/A
Study type: Interventional

In COVID-19 patients hospitalized in the intensive care unit due to respiratory failure, lung ultrasonography will be tried to be given an appropriate position that will effectively use lung capacity and its effect on oxygenation will be investigated.

NCT ID: NCT04431908 Completed - COVID-19 Clinical Trials

Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects

Start date: June 15, 2020
Phase:
Study type: Observational

The purpose of this study is to evaluate the performance of a non-invasive olfactory device as a rapid indicator of COVID-19 in positive subjects.

NCT ID: NCT04431869 Completed - Pregnancy Related Clinical Trials

In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers

Start date: August 18, 2020
Phase:
Study type: Observational [Patient Registry]

The pregnancy related pro-thrombotic state, in addition to the COVID-19 associated hypercoagulability may have unknown consequences to the developing fetus. Hence, this proposal seeks to address this question that may have important implications for women that contract this virus during gestation.

NCT ID: NCT04431453 Completed - COVID-19 Clinical Trials

Study of Remdesivir in Participants Below 18 Years Old With COVID-19

CARAVAN
Start date: July 21, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

The goals of this clinical study are to learn more about the study drug, remdesivir, and how safe it is in participants less than 18 years old with coronavirus disease 2019 (COVID-19).

NCT ID: NCT04431414 Completed - COVID-19 Clinical Trials

A Study of Immune Responses to the Virus That Causes COVID-19

CoVPN 5001
Start date: July 20, 2020
Phase:
Study type: Observational

The purpose of this study is to learn more about the acute response to infection with and recovery from the virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some people know this virus by the name "coronavirus." It can cause the disease called COVID-19. The information gained from the study can be used to help develop better tests for SARS-CoV-2 infection and COVID-19 disease and may help in developing future vaccines, other prevention strategies, and treatments.

NCT ID: NCT04430608 Completed - Covid-19 Clinical Trials

Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients

CGM-ISO
Start date: May 25, 2020
Phase: N/A
Study type: Interventional

This is a randomized controlled trial of isolated patients with diabetes admitted to Nordsjællands Hospital with or without COVID-19-pneumonia. A continuous glucose monitoring (CGM) based system with transmission of glucose data to a central system is used for remote monitoring of glucose levels and compared to standard finger-prick glucose. Blinded (to patients) CGM is mounted in the finger-prick group.

NCT ID: NCT04430322 Completed - COVID Clinical Trials

Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study

COMETE-19
Start date: March 1, 2020
Phase:
Study type: Observational

France and especially the region "Grand Est" have been damaged by the COVID-19 pandemic. This pandemic resulted in a reorganization of the hospitalization sectors. In order to better understand the disease, the investigators wish to carry out a descriptive analysis of hospitalized patient data. This study would notably allow us to identify some prognostic factors. The main objective of this study is to identify individual factors that are associated with a poor prognosis (with ICU admission or death).

NCT ID: NCT04430049 Completed - Covid-19 Clinical Trials

Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients

HAD-Covid
Start date: June 22, 2020
Phase:
Study type: Observational

To limit the pandemic Covid-19 infection, the French government imposed a closure of all Intensive Care Unit (ICU). The family's visitations are prohibited during active Covid -19 pandemic in 2020 and in 2021. This restrictive visit policy could result in an increase in symptoms of anxiety, depression or post-traumatic stress disorder for relatives of ICU patients. The aim of this study is to compare symptoms of anxiety, depression or post-traumatic stress for relatives of ICU patients during Covid period with those during no Covid period (2020 and 2021) with those no Covid period (2022)